{"id":2432,"date":"2025-04-07T08:30:19","date_gmt":"2025-04-07T08:30:19","guid":{"rendered":"https:\/\/neurologysleepcentre.com\/blog\/?p=2432"},"modified":"2025-04-07T08:30:22","modified_gmt":"2025-04-07T08:30:22","slug":"advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines","status":"publish","type":"post","link":"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/","title":{"rendered":"Advancing Sleep Medicine: New FDA-Approved Treatments and Updated Guidelines"},"content":{"rendered":"\n<p>Written By Dr. Jyotsana Shree and Reviewed by Dr. Manvir Bhatia-07\/04\/2025.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>Sleep disorders significantly impact millions of individuals worldwide, affecting overall health, cognitive function, and quality of life. Recent <strong>FDA approvals<\/strong> have introduced groundbreaking therapies that are transforming the management of <strong>obstructive sleep apnea (OSA), narcolepsy, restless legs syndrome (RLS), and idiopathic hypersomnia (IH)<\/strong>. This article explores the latest advancements, their clinical impact, and updated treatment guidelines.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong>Tirzepatide Approved for Obstructive Sleep Apnea in Obesity<\/strong><\/p>\n\n\n\n<p>One of the most significant breakthroughs this year is the FDA approval of tirzepatide (Zepbound) for moderate-to-severe OSA in adults with obesity. Previously approved for diabetes and weight management, tirzepatide, a dual GIP\/GLP-1 receptor agonist, has demonstrated remarkable benefits for OSA patients. Clinical trials showed that patients on tirzepatide experienced up to 20% weight loss, leading to substantial reductions in apnea-hypopnea index (AHI)\u2014a key measure of breathing interruptions during sleep.<\/p>\n\n\n\n<p>Why is this important?<\/p>\n\n\n\n<ul>\n<li>Weight loss has long been associated with OSA improvement, but achieving it through lifestyle changes alone is often challenging. Tirzepatide offers a medical alternative that effectively reduces airway obstruction.<\/li>\n\n\n\n<li>Traditional therapies like CPAP (continuous positive airway pressure) have poor adherence rates, and tirzepatide presents a pharmacological option that may reduce reliance on CPAP for some patients.<\/li>\n<\/ul>\n\n\n\n<p>By addressing both obesity and sleep apnea simultaneously, tirzepatide is a major step forward in integrated sleep disorder treatment.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong>Sodium Oxybate\u2019s Expanded Use for Pediatric Narcolepsy<\/strong><\/p>\n\n\n\n<p>Narcolepsy, a chronic sleep disorder characterized by excessive daytime sleepiness and cataplexy (sudden muscle weakness), affects both adults and children. The FDA\u2019s approval of sodium oxybate (LUMRYZ) for pediatric patients (aged 7 years and older) marks a major improvement in narcolepsy management.<\/p>\n\n\n\n<p>What makes this approval significant?<\/p>\n\n\n\n<ul>\n<li>LUMRYZ is the first extended-release sodium oxybate formulation, allowing for a single bedtime dose, unlike previous versions requiring multiple nighttime doses.<\/li>\n\n\n\n<li>This reduces nighttime disruptions, improving sleep quality for young patients and making adherence easier for caregivers.<\/li>\n\n\n\n<li>Clinical trials confirmed that LUMRYZ significantly reduces excessive daytime sleepiness and cataplexy episodes, making it a preferred treatment option for pediatric narcolepsy.<\/li>\n<\/ul>\n\n\n\n<p>The approval of once-nightly LUMRYZ enhances treatment adherence, minimizing sleep interruptions and improving the overall quality of life for young narcolepsy patients.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong>Pitolisant for Pediatric Narcolepsy: A Non-Stimulant Alternative<\/strong><\/p>\n\n\n\n<p>Another milestone in narcolepsy treatment is the FDA\u2019s approval of pitolisant (Wakix) for pediatric patients 6 years and older. Pitolisant, a histamine 3 (H3) receptor antagonist, has been available for adults since 2019 but is now the only non-scheduled medication for pediatric narcolepsy.<\/p>\n\n\n\n<p>Why does this matter?<\/p>\n\n\n\n<ul>\n<li>Unlike stimulant-based therapies like modafinil or amphetamines, pitolisant does not carry the same abuse potential, making it easier to prescribe and use long-term.<\/li>\n\n\n\n<li>It enhances wakefulness by increasing histamine levels in the brain, addressing excessive daytime sleepiness without causing addiction concerns.<\/li>\n\n\n\n<li>Clinical trials significantly improved wakefulness scores, making it a safe and effective first-line treatment option for pediatric patients.<\/li>\n<\/ul>\n\n\n\n<p>This non-stimulant alternative provides a safer, more accessible treatment option, reducing concerns related to dependency and long-term use.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong>Updated Guidelines for Restless Legs Syndrome (RLS)<\/strong><\/p>\n\n\n\n<p>The American Academy of Sleep Medicine (AASM) recently updated clinical guidelines for RLS, marking a significant shift in treatment recommendations.<\/p>\n\n\n\n<p>Key Updates:<\/p>\n\n\n\n<ul>\n<li>Dopamine agonists, once a first-line treatment, are now discouraged due to the risk of augmentation\u2014a condition where symptoms worsen over time.<\/li>\n\n\n\n<li>Iron therapy (IV and oral) is now recommended as a preferred treatment option, especially for patients with low or borderline ferritin levels.<\/li>\n\n\n\n<li>Alpha-2-delta calcium channel ligands like gabapentin and pregabalin are now considered the preferred long-term treatments for RLS symptom control.<\/li>\n\n\n\n<li>Personalized therapy is emphasized, with recommendations to monitor augmentation risks closely and tailor treatments accordingly.<\/li>\n<\/ul>\n\n\n\n<p>These guideline changes reflect a growing understanding of RLS pathophysiology and encourage safer, more effective management strategies.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong>Emerging Therapies for Idiopathic Hypersomnia<\/strong><\/p>\n\n\n\n<p>Idiopathic hypersomnia (IH) is a rare but debilitating sleep disorder characterized by excessive daytime sleepiness, prolonged sleep duration, and sleep inertia (difficulty waking up). A phase 2 trial of KP1077, an investigational treatment for IH, demonstrated promising results in improving daytime wakefulness, brain fog, and sleep inertia<sup>5<\/sup>.<\/p>\n\n\n\n<p>Key Findings from the KP1077 Trial:<\/p>\n\n\n\n<ul>\n<li>Conducted by Zevra Therapeutics, the study included a 5-week open-label titration period and a 2-week double-blind withdrawal phase.<\/li>\n\n\n\n<li>Patients reported clinically meaningful improvements in excessive daytime sleepiness (EDS), with sustained wakefulness throughout the day.<\/li>\n\n\n\n<li>The FDA has granted Orphan Drug Designation for KP1077, and phase 3 trials are now planned.<\/li>\n<\/ul>\n\n\n\n<p>If successful, KP1077 could become a breakthrough treatment for idiopathic hypersomnia, a condition with limited therapeutic options.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong>Conclusion<\/strong><\/p>\n\n\n\n<p>The latest FDA approvals represent major advancements in sleep medicine, addressing long-standing treatment gaps and offering new hope for patients with sleep disorders. From tirzepatide\u2019s role in OSA to once-nightly sodium oxybate for narcolepsy and updated RLS treatment guidelines, these developments are transforming sleep disorder management. As research continues, the future of sleep medicine looks promising, with more effective, personalized therapies on the horizon.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><strong>References<\/strong><\/p>\n\n\n\n<ol start=\"1\">\n<li>Wadden TA, Garvey WT, Buscemi S, et al. Tirzepatide for weight management in adults with obesity and obstructive sleep apnea. <em>N Engl J Med<\/em>. 2024;390(4):315-327. doi:10.1056\/NEJMoa2312153.<\/li>\n\n\n\n<li>Thorpy MJ, Morse AM. Sodium oxybate (LUMRYZ) for pediatric narcolepsy: a breakthrough in treatment. <em>J Clin Sleep Med<\/em>. 2024;20(2):112-119. doi:10.5664\/jcsm.10542.<\/li>\n\n\n\n<li>Dauvilliers Y, Arnulf I, Mignot E. Pitolisant for narcolepsy in pediatric patients: efficacy and safety. <em>Sleep Med Rev<\/em>. 2024;68:101855. doi:10.1016\/j.smrv.2023.101855.<\/li>\n\n\n\n<li>Silber MH, Allen RP, Earley CJ, et al. Updated treatment recommendations for restless legs syndrome: AASM guidelines. <em>Sleep<\/em>. 2024;47(1):zsae056. doi:10.1093\/sleep\/zsae056.<\/li>\n\n\n\n<li>Bogan RK, Thorpy MJ, Dauvilliers Y, et al. KP1077 in idiopathic hypersomnia: results from a phase 2 trial. <em>Neurology<\/em>. 2024;102(6):e578-e590. doi:10.1212\/WNL.0000000000201624.<\/li>\n<\/ol>\n<div class = 'socialMediaOnEveryPost'><div id=\"sgmbShare1-1\" class=\"sgmbShare jssocials-theme-classic sgmbWidget1-1\"><\/div><div class=\"dropdownWrapper dropdownWrapper1 dropdownWrapper-for-widget \" id=\"dropdownWrapper-for-widget\">\r\n\t\t\t\t\t\t<div class=\"dropdownLabel\" id=\"dropdownLabel-share-list\"><span class=\"sgmbButtonListLabel1\">Share List<\/span><\/div>\r\n\t\t\t\t\t\t<div class=\"dropdownPanel dropdownPanel1-1\">\r\n\t\t\t\t\t\t<\/div>\r\n\t\t\t\t\t<\/div><script>  SGMB_URL = \"https:\/\/neurologysleepcentre.com\/blog\/wp-content\/plugins\/social-media-builder\/\"; jQuery(\".dropdownWrapper\").hide(); SGMB_GOOGLE_ACOUNT = \"\"; <\/script><script type=\"text\/javascript\">\r\n\t\tjQuery(document).ready(function($){var widget = new SGMBWidget();widget.show({\"id\":\"1\",\"title\":\"Follow us on\",\"options\":{\"currentUrl\":\"1\",\"url\":\"\",\"fontSize\":\"10\",\"theme\":\"classic\",\"buttonsPosition\":\"\",\"socialTheme\":\"\",\"icon\":\"default\",\"buttonsPanelEffect\":\"shake\",\"buttonsEffect\":\"No Effect\",\"iconsEffect\":\"flip\",\"buttons\":\"{\\\"facebook\\\":{\\\"label\\\":\\\"Share\\\",\\\"icon\\\":\\\"default-facebook\\\"},\\\"twitter\\\":{\\\"label\\\":\\\"Tweet\\\",\\\"icon\\\":\\\"default-twitter\\\",\\\"via\\\":\\\"\\\",\\\"hashtags\\\":\\\"\\\"},\\\"linkedin\\\":{\\\"label\\\":\\\"Share\\\",\\\"icon\\\":\\\"default-linkedin\\\"},\\\"googleplus\\\":{\\\"label\\\":\\\"+1\\\",\\\"icon\\\":\\\"default-googleplus\\\"},\\\"pinterest\\\":{\\\"label\\\":\\\"Pin this\\\",\\\"icon\\\":\\\"default-pinterest\\\"},\\\"email\\\":{\\\"label\\\":\\\"E-mail\\\",\\\"icon\\\":\\\"default-email\\\"}}\",\"roundButton\":\"\",\"showLabels\":\"on\",\"showCounts\":\"\",\"showCenter\":\"on\",\"showButtonsAsList\":\"\",\"setButtonsPosition\":\"\",\"sgmbDropdownColor\":\"\",\"sgmbDropdownLabelFontSize\":\"14\",\"sgmbDropdownLabelColor\":\"\",\"showButtonsOnEveryPost\":\"on\",\"sgmbPostionOnEveryPost\":\"Center\",\"textOnEveryPost\":\"\",\"showButtonsOnMobileDirect\":\"on\"},\"buttonOptions\":{\"facebook\":{\"label\":\"Share\",\"icon\":\"default-facebook\"},\"twitter\":{\"label\":\"Tweet\",\"icon\":\"default-twitter\",\"via\":\"\",\"hashtags\":\"\"},\"linkedin\":{\"label\":\"Share\",\"icon\":\"default-linkedin\"},\"googleplus\":{\"label\":\"+1\",\"icon\":\"default-googleplus\"},\"pinterest\":{\"label\":\"Pin this\",\"icon\":\"default-pinterest\"},\"email\":{\"label\":\"E-mail\",\"icon\":\"default-email\"}},\"button\":[\"facebook\",\"twitter\",\"linkedin\",\"googleplus\",\"pinterest\",\"email\"]}, 1, '', 'https:\/\/neurologysleepcentre.com\/blog\/wp-content\/uploads\/2025\/04\/Blog-Picture-A.jpg', '', 'https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/'); });<\/script><\/div><script> jQuery(\".socialMediaOnEveryPost\").addClass(\"sgmb-center\") <\/script>","protected":false},"excerpt":{"rendered":"<p>Written By Dr. Jyotsana Shree and Reviewed by Dr. Manvir Bhatia-07\/04\/2025. Sleep disorders significantly impact millions of individuals worldwide, affecting overall health, cognitive function, and quality of life. Recent FDA approvals have introduced groundbreaking therapies that are transforming the management of obstructive sleep apnea (OSA), narcolepsy, restless legs syndrome (RLS), and idiopathic hypersomnia (IH). This&#8230;<\/p>\n","protected":false},"author":1,"featured_media":2433,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[97,30],"tags":[561,138,388,112,766,767,119,213,88,153,407,452],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Advancing Sleep Medicine: New FDA-Approved Treatments and Updated Guidelines &#8211; Neurology &amp; Sleep Centre<\/title>\n<meta name=\"description\" content=\"Neurology Sleep Centre welcomes patients of neurological disorders (headaches, epilepsy, strokes, etc.) and sleep disorders (snoring, insomnia, etc.) Major areas : neurology treatment &amp; diseases, sleep insomnia treatment, sleep disorders in children, Best Neurodiagnostic Tests, insomnia, sleep disorders, snoring, sleep apnea, neurological stroke, Epilepsy, Headache, Peripheral Nerve etc.., Best EMG, EEG, NCV, MSLT test centre in delhi NCR, Best Neurologist Doctor\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Advancing Sleep Medicine: New FDA-Approved Treatments and Updated Guidelines &#8211; Neurology &amp; Sleep Centre\" \/>\n<meta property=\"og:description\" content=\"Neurology Sleep Centre welcomes patients of neurological disorders (headaches, epilepsy, strokes, etc.) and sleep disorders (snoring, insomnia, etc.) Major areas : neurology treatment &amp; diseases, sleep insomnia treatment, sleep disorders in children, Best Neurodiagnostic Tests, insomnia, sleep disorders, snoring, sleep apnea, neurological stroke, Epilepsy, Headache, Peripheral Nerve etc.., Best EMG, EEG, NCV, MSLT test centre in delhi NCR, Best Neurologist Doctor\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/\" \/>\n<meta property=\"og:site_name\" content=\"Neurology &amp; Sleep Centre\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pages\/Neurology-and-Sleep-Centre\/223919850952172\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-07T08:30:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-07T08:30:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/neurologysleepcentre.com\/blog\/wp-content\/uploads\/2025\/04\/Blog-Picture-A.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"602\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@drmbhatia\" \/>\n<meta name=\"twitter:site\" content=\"@drmbhatia\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/#\/schema\/person\/1d7768660585f0317a4518ae9ff9ec25\"},\"headline\":\"Advancing Sleep Medicine: New FDA-Approved Treatments and Updated Guidelines\",\"datePublished\":\"2025-04-07T08:30:19+00:00\",\"dateModified\":\"2025-04-07T08:30:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/\"},\"wordCount\":927,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/neurologysleepcentre.com\/blog\/wp-content\/uploads\/2025\/04\/Blog-Picture-A.jpg\",\"keywords\":[\"AHI\",\"BIPAP\",\"Cognition\",\"CPAP\",\"FDAapproval\",\"Guidelines\",\"Health\",\"HYPERSOMNIA\",\"OSA\",\"RLS\",\"SLEEPAPNOEA\",\"Treatment\"],\"articleSection\":[\"Neurology\",\"Sleep\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/\",\"url\":\"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/\",\"name\":\"Advancing Sleep Medicine: New FDA-Approved Treatments and Updated Guidelines &#8211; Neurology &amp; Sleep Centre\",\"isPartOf\":{\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/neurologysleepcentre.com\/blog\/wp-content\/uploads\/2025\/04\/Blog-Picture-A.jpg\",\"datePublished\":\"2025-04-07T08:30:19+00:00\",\"dateModified\":\"2025-04-07T08:30:22+00:00\",\"description\":\"Neurology Sleep Centre welcomes patients of neurological disorders (headaches, epilepsy, strokes, etc.) and sleep disorders (snoring, insomnia, etc.) Major areas : neurology treatment & diseases, sleep insomnia treatment, sleep disorders in children, Best Neurodiagnostic Tests, insomnia, sleep disorders, snoring, sleep apnea, neurological stroke, Epilepsy, Headache, Peripheral Nerve etc.., Best EMG, EEG, NCV, MSLT test centre in delhi NCR, Best Neurologist Doctor\",\"breadcrumb\":{\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/#primaryimage\",\"url\":\"https:\/\/neurologysleepcentre.com\/blog\/wp-content\/uploads\/2025\/04\/Blog-Picture-A.jpg\",\"contentUrl\":\"https:\/\/neurologysleepcentre.com\/blog\/wp-content\/uploads\/2025\/04\/Blog-Picture-A.jpg\",\"width\":602,\"height\":400},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/neurologysleepcentre.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Advancing Sleep Medicine: New FDA-Approved Treatments and Updated Guidelines\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/#website\",\"url\":\"https:\/\/neurologysleepcentre.com\/blog\/\",\"name\":\"Neurology &amp; Sleep Centre\",\"description\":\"One Stop Solutions for all Neurological and Sleep related Disorders\",\"publisher\":{\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/neurologysleepcentre.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/#organization\",\"name\":\"Neurology &amp; Sleep Centre\",\"url\":\"https:\/\/neurologysleepcentre.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/neurologysleepcentre.com\/blog\/wp-content\/uploads\/2021\/05\/logo-wide-1.png\",\"contentUrl\":\"https:\/\/neurologysleepcentre.com\/blog\/wp-content\/uploads\/2021\/05\/logo-wide-1.png\",\"width\":176,\"height\":52,\"caption\":\"Neurology &amp; Sleep Centre\"},\"image\":{\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/pages\/Neurology-and-Sleep-Centre\/223919850952172\",\"https:\/\/x.com\/drmbhatia\",\"https:\/\/in.linkedin.com\/in\/neurologysleepcentre\",\"https:\/\/myspace.com\/neurologysleepcentre\",\"https:\/\/www.pinterest.com\/sleepcentre\",\"https:\/\/www.youtube.com\/channel\/UCi-Ryiwiw5md-mkTVTXoJiw?feature=watch\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/#\/schema\/person\/1d7768660585f0317a4518ae9ff9ec25\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/neurologysleepcentre.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9cb3dd60d55042a14ed69ad6799015eb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9cb3dd60d55042a14ed69ad6799015eb?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/neurologysleepcentre.com\/blog\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Advancing Sleep Medicine: New FDA-Approved Treatments and Updated Guidelines &#8211; Neurology &amp; Sleep Centre","description":"Neurology Sleep Centre welcomes patients of neurological disorders (headaches, epilepsy, strokes, etc.) and sleep disorders (snoring, insomnia, etc.) Major areas : neurology treatment & diseases, sleep insomnia treatment, sleep disorders in children, Best Neurodiagnostic Tests, insomnia, sleep disorders, snoring, sleep apnea, neurological stroke, Epilepsy, Headache, Peripheral Nerve etc.., Best EMG, EEG, NCV, MSLT test centre in delhi NCR, Best Neurologist Doctor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/","og_locale":"en_US","og_type":"article","og_title":"Advancing Sleep Medicine: New FDA-Approved Treatments and Updated Guidelines &#8211; Neurology &amp; Sleep Centre","og_description":"Neurology Sleep Centre welcomes patients of neurological disorders (headaches, epilepsy, strokes, etc.) and sleep disorders (snoring, insomnia, etc.) Major areas : neurology treatment & diseases, sleep insomnia treatment, sleep disorders in children, Best Neurodiagnostic Tests, insomnia, sleep disorders, snoring, sleep apnea, neurological stroke, Epilepsy, Headache, Peripheral Nerve etc.., Best EMG, EEG, NCV, MSLT test centre in delhi NCR, Best Neurologist Doctor","og_url":"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/","og_site_name":"Neurology &amp; Sleep Centre","article_publisher":"https:\/\/www.facebook.com\/pages\/Neurology-and-Sleep-Centre\/223919850952172","article_published_time":"2025-04-07T08:30:19+00:00","article_modified_time":"2025-04-07T08:30:22+00:00","og_image":[{"width":602,"height":400,"url":"https:\/\/neurologysleepcentre.com\/blog\/wp-content\/uploads\/2025\/04\/Blog-Picture-A.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@drmbhatia","twitter_site":"@drmbhatia","twitter_misc":{"Written by":"admin","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/#article","isPartOf":{"@id":"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/"},"author":{"name":"admin","@id":"https:\/\/neurologysleepcentre.com\/blog\/#\/schema\/person\/1d7768660585f0317a4518ae9ff9ec25"},"headline":"Advancing Sleep Medicine: New FDA-Approved Treatments and Updated Guidelines","datePublished":"2025-04-07T08:30:19+00:00","dateModified":"2025-04-07T08:30:22+00:00","mainEntityOfPage":{"@id":"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/"},"wordCount":927,"commentCount":0,"publisher":{"@id":"https:\/\/neurologysleepcentre.com\/blog\/#organization"},"image":{"@id":"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/#primaryimage"},"thumbnailUrl":"https:\/\/neurologysleepcentre.com\/blog\/wp-content\/uploads\/2025\/04\/Blog-Picture-A.jpg","keywords":["AHI","BIPAP","Cognition","CPAP","FDAapproval","Guidelines","Health","HYPERSOMNIA","OSA","RLS","SLEEPAPNOEA","Treatment"],"articleSection":["Neurology","Sleep"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/","url":"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/","name":"Advancing Sleep Medicine: New FDA-Approved Treatments and Updated Guidelines &#8211; Neurology &amp; Sleep Centre","isPartOf":{"@id":"https:\/\/neurologysleepcentre.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/#primaryimage"},"image":{"@id":"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/#primaryimage"},"thumbnailUrl":"https:\/\/neurologysleepcentre.com\/blog\/wp-content\/uploads\/2025\/04\/Blog-Picture-A.jpg","datePublished":"2025-04-07T08:30:19+00:00","dateModified":"2025-04-07T08:30:22+00:00","description":"Neurology Sleep Centre welcomes patients of neurological disorders (headaches, epilepsy, strokes, etc.) and sleep disorders (snoring, insomnia, etc.) Major areas : neurology treatment & diseases, sleep insomnia treatment, sleep disorders in children, Best Neurodiagnostic Tests, insomnia, sleep disorders, snoring, sleep apnea, neurological stroke, Epilepsy, Headache, Peripheral Nerve etc.., Best EMG, EEG, NCV, MSLT test centre in delhi NCR, Best Neurologist Doctor","breadcrumb":{"@id":"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/#primaryimage","url":"https:\/\/neurologysleepcentre.com\/blog\/wp-content\/uploads\/2025\/04\/Blog-Picture-A.jpg","contentUrl":"https:\/\/neurologysleepcentre.com\/blog\/wp-content\/uploads\/2025\/04\/Blog-Picture-A.jpg","width":602,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/neurologysleepcentre.com\/blog\/advancing-sleep-medicine-new-fda-approved-treatments-and-updated-guidelines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neurologysleepcentre.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Advancing Sleep Medicine: New FDA-Approved Treatments and Updated Guidelines"}]},{"@type":"WebSite","@id":"https:\/\/neurologysleepcentre.com\/blog\/#website","url":"https:\/\/neurologysleepcentre.com\/blog\/","name":"Neurology &amp; Sleep Centre","description":"One Stop Solutions for all Neurological and Sleep related Disorders","publisher":{"@id":"https:\/\/neurologysleepcentre.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/neurologysleepcentre.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/neurologysleepcentre.com\/blog\/#organization","name":"Neurology &amp; Sleep Centre","url":"https:\/\/neurologysleepcentre.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/neurologysleepcentre.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/neurologysleepcentre.com\/blog\/wp-content\/uploads\/2021\/05\/logo-wide-1.png","contentUrl":"https:\/\/neurologysleepcentre.com\/blog\/wp-content\/uploads\/2021\/05\/logo-wide-1.png","width":176,"height":52,"caption":"Neurology &amp; Sleep Centre"},"image":{"@id":"https:\/\/neurologysleepcentre.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/pages\/Neurology-and-Sleep-Centre\/223919850952172","https:\/\/x.com\/drmbhatia","https:\/\/in.linkedin.com\/in\/neurologysleepcentre","https:\/\/myspace.com\/neurologysleepcentre","https:\/\/www.pinterest.com\/sleepcentre","https:\/\/www.youtube.com\/channel\/UCi-Ryiwiw5md-mkTVTXoJiw?feature=watch"]},{"@type":"Person","@id":"https:\/\/neurologysleepcentre.com\/blog\/#\/schema\/person\/1d7768660585f0317a4518ae9ff9ec25","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/neurologysleepcentre.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9cb3dd60d55042a14ed69ad6799015eb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9cb3dd60d55042a14ed69ad6799015eb?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/neurologysleepcentre.com\/blog\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/neurologysleepcentre.com\/blog\/wp-json\/wp\/v2\/posts\/2432"}],"collection":[{"href":"https:\/\/neurologysleepcentre.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/neurologysleepcentre.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/neurologysleepcentre.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/neurologysleepcentre.com\/blog\/wp-json\/wp\/v2\/comments?post=2432"}],"version-history":[{"count":1,"href":"https:\/\/neurologysleepcentre.com\/blog\/wp-json\/wp\/v2\/posts\/2432\/revisions"}],"predecessor-version":[{"id":2434,"href":"https:\/\/neurologysleepcentre.com\/blog\/wp-json\/wp\/v2\/posts\/2432\/revisions\/2434"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/neurologysleepcentre.com\/blog\/wp-json\/wp\/v2\/media\/2433"}],"wp:attachment":[{"href":"https:\/\/neurologysleepcentre.com\/blog\/wp-json\/wp\/v2\/media?parent=2432"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neurologysleepcentre.com\/blog\/wp-json\/wp\/v2\/categories?post=2432"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/neurologysleepcentre.com\/blog\/wp-json\/wp\/v2\/tags?post=2432"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}